Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Lin Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0264-6433; OpenAlex author ID A5103850867. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome. Co-author DOI 10.1038/s41598-025-12651-x↗
  2. Triptolide suppresses pancreatic cancer cell proliferation by inhibiting hedgehog signaling pathway activity. Co-author DOI 10.1007/s11427-018-9477-3↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Zhang · 1 shared paper, 2025 · strength 0.28
  2. Xia Yuan · 1 shared paper, 2025 · strength 0.28
  3. Juanjuan Feng · 1 shared paper, 2019 · strength 0.10
  4. Xiufeng Pang · 1 shared paper, 2019 · strength 0.10
  5. Zhenliang Sun · 1 shared paper, 2019 · strength 0.10
  6. Weiqiang Lü · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.